QUALITY OF LIFE IN CHRONIC SYMPTOMATIC HEART FAILURE PATIENTS IN SPAIN

Author(s)

Marti B1, Delgado J2, Oliva J3, Llano M4, Pascual P5, Comin J6, Grillo JJ7, Diaz Molina B8, Culebras J9, Martínez de la Concha L10, Manito N111Medtronic Iberia, Madrid, Spain, 2Hospital 12 de Octubre, Madrid, Spain, 3Universidad de Castilla La Mancha, Toledo, Spain, 4Hospital Universitario Marqués de Valdecilla, Santander, Spain, 5Hospital Universitario Virgen de la Arrixaca, Murcia, Spain, 6Hospital del Mar (IMIM), Barcelona, Spain, 7Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain, 8Hospital Universitario Central de Asturias, Oviedo, Spain, 9Hospital Universitario Insular, Las Palmas De Gran Canaria, Spain, 10Hospital Universitario Infanta Cristina, Badajoz, Spain, 11Hospital de Bellvitge, Barcelona, Spain

OBJECTIVES:  To analyze, for the first time in a large Spanish population of heart failure patients, quality of life according to NYHA class II, III or IV using generic and specific quality of life questionnaires. METHODS: A descriptive analysis of a multicenter, prospective observational study was performed. Patients who met inclusion criteria were followed-up for a period of 12 months, with 3 visits programmed at baseline, 6 months and 12 months. A total of 9 Spanish hospitals were involved in the study. Questionnaires used to measure quality of life were: EQ-5D (generic questionnaire), Minessotta living with heart failure- MLWHF (specific questionnaire) and Barthel Index (index of independence). RESULTS: A total of 450 patients were included, 76% men, mean age was 62.6 years. 66.1% were in NYHA class II, 32.7% NYHA class III and 1.1% NYHA class IV. Prevalence of ischemic cardiopathy was 33.5%. 35% of patients had an implantable device (ICD, RCT or pacemaker). Significant differences were observed in Barthel Index’s scores depending on class: class I 97.6 ± 6.7 vs. Class III-IV 91.8 ± 14.6. Related to EQ-5D tariffs, individuals in class II had a mean value of 0.8407 ± 0.1887 (out of 1), and mean VAS value of 60.6 ± 17.39 (out of 100). Individuals in NYHA class III or IV had a mean score of 0.6624 ± 0.2848, and mean VAS value of 51.93 ± 17.15 (out of 100). In a MLWHF questionnaire analyses, patients in NYHA class II showed a mean score of 32.52 ± 20.69 while patient in NYHA class III-IV showed a mean score of 50.44 ± 18.23. CONCLUSIONS: Our findings showed the results from the three questionnaires were generally consistent with each other and values reported from other countries in the literature.

Conference/Value in Health Info

2010-11, ISPOR Europe 2010, Prague, Czech Republic

Value in Health, Vol. 13, No. 7 (November 2010)

Code

PCV116

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×